Your browser doesn't support javascript.
loading
The Dolaflexin-based Antibody-Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b.
Bodyak, Natalya D; Mosher, Rebecca; Yurkovetskiy, Aleksandr V; Yin, Mao; Bu, Charlie; Conlon, Patrick R; Demady, Damon R; DeVit, Michael J; Gumerov, Dmitry R; Gurijala, Venu R; Lee, Winnie; McGillicuddy, Dennis; Park, Peter U; Poling, Laura L; Protopova, Marina; Qin, LiuLiang; Stevenson, Cheri A; Ter-Ovanesyan, Elena; Uttard, Alex; Xiao, Dongmei; Xu, Jian; Xu, Ling; Bergstrom, Donald A; Lowinger, Timothy B.
Afiliação
  • Bodyak ND; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Mosher R; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Yurkovetskiy AV; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Yin M; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Bu C; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Conlon PR; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Demady DR; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • DeVit MJ; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Gumerov DR; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Gurijala VR; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Lee W; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • McGillicuddy D; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Park PU; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Poling LL; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Protopova M; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Qin L; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Stevenson CA; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Ter-Ovanesyan E; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Uttard A; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Xiao D; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Xu J; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Xu L; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Bergstrom DA; Mersana Therapeutics, Inc., Cambridge, Massachusetts.
  • Lowinger TB; Mersana Therapeutics, Inc., Cambridge, Massachusetts. tlowinger@mersana.com.
Mol Cancer Ther ; 20(5): 896-905, 2021 05.
Article em En | MEDLINE | ID: mdl-33722858
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Polímeros / Imunoconjugados / Antígenos de Neoplasias / Neoplasias Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Polímeros / Imunoconjugados / Antígenos de Neoplasias / Neoplasias Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2021 Tipo de documento: Article